AHNAK
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Korea Health Industry Development Institute and 3 more
- Humans1
- Animals3
Upstream
2End-stage renal disease
downin humans1
1 study
End-stage renal disease
downin humans1
End-stage renal disease decreases AHNAK in humans.
“Plasma AHNAK protein levels was higher in the sarcopenia group but was lower in the ESRD group.”
Humansend-stage renal diseaseplasman = 22
Journal of cachexia, sarcopenia and muscle
Sarcopenia
upin humans1
1 study
Sarcopenia
upin humans1
Sarcopenia increases AHNAK in humans.
“Plasma AHNAK protein levels was higher in the sarcopenia group but was lower in the ESRD group.”
Humansprimary sarcopeniaplasman = 28
Journal of cachexia, sarcopenia and muscle
Latest
1 paper in 12 monthsBiochimica et Biophysica Acta Molecular Basis of Disease
p300/Ahnak1 promotes the depression of ICa,L of atrial myocytes induced by aging
Experiments in miceMechanisms
Journal of Cachexia, Sarcopenia and Muscle
Comparative Analysis of Primary Sarcopenia and End-Stage Renal Disease-Related Muscle Wasting Using Multi-Omics Approaches
Cohort study of 78 peopleKidney
BMC Research Notes
Decoding the transcriptomic expression and genomic methylation patterns in the tendon proper and its peritenon region in the aging horse
Experiments in horsesDNA methylation
Journal of Cachexia, Sarcopenia and Muscle
Age-related decline in murine heart and skeletal muscle performance is attenuated by reduced Ahnak1 expression
Experiments in miceMuscle